AdGene Biosciences
Tracked across 1 events · 9 articles · First seen Sep 10, 2026 · Last active Sep 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
AdGene Biosciences, a clinical-stage next-generation vaccine platform company based in Delft, Netherlands, announced on September 10, 2026 the publication of a new White Paper titled Boosting mRNA: Mucosal Immunity and a Platform Beyond It. The…
Impact: AdJane is the sole protagonist of the event, publishing the White Paper and promoting its Nm-nOMV mucosal booster platform. The disclosure could support its partnering and valuation narrative, though it remains clinical-stage with no approved product.
Sep 10, 2026 · 9 articles
80
AdGene Biosciences published white paperAdJane Mucosal Booster White Paper
70
AdGene Biosciences completed Phase I studyAdJane Mucosal Booster White Paper
50
AdGene Biosciences filed patent applicationsAdJane Mucosal Booster White Paper
ERGEN INTELLIGENCE
Track AdGene Biosciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard